Cell study · human brain organoids

Thymosin beta-4 rescued AD-linked defects in human brain organoids

Checked against the paper Cell studyPublished by PepVault

The takeaway

Early lab evidence ties lower thymosin beta-4 levels to Alzheimer-type changes, with treatment rescuing some of them in organoids and showing benefits in mice, but no human treatment data yet.

Kind
Cell study
Studied in
Human brain organoids
Published
2025
Journal
Stem Cell Reports

What they tested

The team asked whether thymosin beta-4 (Tβ4) is linked to Alzheimer disease changes in developing brain tissue, and whether giving it could reverse them.

How the study was done

A lab study using brain organoids, small lab-grown models of brain tissue, made from induced pluripotent stem cells (stem cells reprogrammed from adult cells). Some carried mutations in the APP gene tied to inherited Alzheimer disease and were compared with healthy-control organoids, and Tβ4 was also tested in 5xFAD model mice.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In human brain organoids with the inherited Alzheimer mutations, mature neurons dropped sharply compared with healthy controls, while cell senescence (cells that have stopped dividing and aged) and beta-amyloid (Aβ) production rose. The gene that makes Tβ4, TMSB4X, was expressed at lower levels in the mutant organoids' neurons and in excitatory neurons from people with Alzheimer disease. Treating the organoids with Tβ4 rescued the neuron development deficits and the Aβ formation. In 5xFAD mice, Tβ4 also had beneficial effects.

What it doesn’t show

This is work in lab-grown organoids and mice, so it does not show that Tβ4 treats or prevents Alzheimer disease in people. The study tested full-length thymosin beta-4, not the shorter TB-500 fragment.

The paper

Zeng et al. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoids. Stem Cell Reports. 2025.

The compounds

More studies on Thymosin Beta-4

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking Thymosin Beta-4? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo